Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation

NCT02608099 is registered in ClinicalTrials.gov with Baim Institute for Clinical Research as lead sponsor.

NCT NCT02608099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02608099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apixaban Evaluation of Interrupted Or Uninterrupted Anticoagulation for Ablation of Atrial Fibrillation
Lead sponsor
Baim Institute for Clinical Research
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2015
Completion date
April 30, 2017
Enrollment
300 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation